Autor Título Original / Colaboración Selecciona una opción Original Colaboración Año Selecciona un año20152016201720182019202020212022202320242025 Cuartil Selecciona un cuartilD1Q1Q2Q3Q4 Tipo Selecciona un tipo#N/DArticleArtículoBook ChapterBook ReviewClinical TrialCommentaryCorrectionData PaperEditorialEditorial MaterialExpression of ConcernLetterProceedings PaperReprintReview Revista Should Hydroxyisohexyl 3-Cyclohexene Carboxaldehyde (Lyral®) still be part of the Baseline Series? Autores: Fernández, CPH; Borrego, L; Arnau, AMG; Sánchez, TS; Carrillo, JMC; Ninet, VZ; Baldrich, ES; Miquel, FJM; Salvador, JFS; Guijarro, SC; Gilo, AS; García, PM; Triviño, FN; Romero, FT; Serna, MR; Ninot, GM; González, IR; de la Fuente, EG; Nieto, MAP; Guillén, PSP; Pérez, JS; Rodríguez, JJP; Ortega, MEG; Pérez, RG; Doval, IG; Descalzo, MAG Scombroidosis. A diagnosis to consider Autores: Medina-Cobos, A; Cabrerizo-Carvajal, A; Ruiz-Villaverde, R Secukinumab for Treatment of Plaque Psoriasis in Real-World Clinical Practice in Spain: A Literature Review Autores: Dauden, E; Ortiz-Salvador, JM; Notario, J; Puig, L; Santos-Juanes, J; Herrera-Acosta, E; Gomez-Labrador, L; Ruiz-Villaverde, R Seborrheic Dermatitis Revisited: Pathophysiology, Diagnosis, and Emerging Therapies-A Narrative Review Autores: Triviño, FJN; Amador, JPV; Ruiz, IR Relapsing polychondritis Autores: Vargas-Castillo, G; Zulaika-Lloret, M; Ruiz-Villaverde, R Real-World Clinical, Psychosocial and Financial Burden of Atopic Dermatitis: Results from the Spanish Cohort of the MEASURE-AD Trial Autores: Silvestre, JF; Ruiz-Villaverde, R; Pérez-García, B; Pinto, PH; Domínguez-Cruz, JJ; Gentile, M; Belloso, RMI RF – OX40: A Promising Therapeutic Target in Moderate-to-severe Atopic Dermatitis Autores: Zulaika-Lloret, M; Rodriguez-Troncoso, M; Ruiz-Villaverde, R < 1 2 … 124 125 126 … 1.706 1.707 >
